Cowden syndrome laboratory findings: Difference between revisions
Line 35: | Line 35: | ||
OR | OR | ||
Laboratory findings consistent with the diagnosis of | Laboratory findings consistent with the diagnosis of cowden syndrome include: | ||
* | *CBC count: | ||
* | *Thyroid function tests | ||
* | *Urinalysis | ||
*Calcium level | |||
*Skin biopsy | |||
OR | OR |
Revision as of 17:23, 7 March 2019
Cowden syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cowden syndrome laboratory findings On the Web |
American Roentgen Ray Society Images of Cowden syndrome laboratory findings |
Risk calculators and risk factors for Cowden syndrome laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
OR
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
OR
[Test] is usually normal for patients with [disease name].
OR
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
OR
There are no diagnostic laboratory findings associated with [disease name].
Laboratory Findings
There are no diagnostic laboratory findings associated with [disease name].
OR
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
OR
[Test] is usually normal among patients with [disease name].
OR
Laboratory findings consistent with the diagnosis of cowden syndrome include:
- CBC count:
- Thyroid function tests
- Urinalysis
- Calcium level
- Skin biopsy
OR
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
- PTEN mutation testing by following:
- Sequence analysis of coding region
- Deletion/duplication analysis
- Sequence analysis of promoter region
References
- ↑ Pilarski R, Stephens JA, Noss R, Fisher JL, Prior TW (August 2011). "Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features". J. Med. Genet. 48 (8): 505–12. doi:10.1136/jmg.2011.088807. PMID 21659347.
- ↑ Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E (November 2013). "Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria". J. Natl. Cancer Inst. 105 (21): 1607–16. doi:10.1093/jnci/djt277. PMID 24136893.